iTeos Therapeutics, Inc. announced the promotion of Yvonne McGrath, Ph.D., to chief scientific officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 USD | +1.43% | -3.96% | +55.07% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.07% | 624M | |
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- ITeos Therapeutics, Inc. Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer